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S U M M A R Y
Objectives: To gain an insight into the genetic diversity of multidrug-resistant (MDR) Mycobacterium
tuberculosis isolates in Chongqing Municipality, an MDR tuberculosis (MDR-TB) epidemic region of
China.
Methods: In this study, a total of 208 M. tuberculosis isolates from smear-positive TB patients in
Chongqing were genotyped by spoligotyping and mycobacterial interspersed repetitive unit–variable
number tandem repeat typing (MIRU-VNTR). In addition, statistical analysis was performed to evaluate
the distributions of drug susceptibility patterns and demographic data among different genotypes.
Results: Our results showed that 156 MDR M. tuberculosis strains (75.0%) belonged to the Beijing
genotype, while the other 52 strains (25.0%) were non-Beijing genotype. The proportion of Beijing
genotype in the re-treated patient group was signiﬁcantly higher than that in the new patient group
(p = 0.013), while drug resistance and demographic characteristics showed no statistically signiﬁcant
associations with Beijing genotype (p > 0.05). In addition, the 208 strains were clustered into
193 genotypes using a 10-locus VNTR set; the cumulative clustering rate was 12.98% and the HGDI was
0.9991.
Conclusions: Beijing genotype was the predominant genotype among the isolates from MDR-TB cases in
Chongqing. The re-treated MDR-TB cases were more likely to be attributed to Beijing genotype infection.
The 10-locus VNTR set demonstrated a good discrimination power for genotyping MDR M. tuberculosis
isolates circulating in Chongqing Municipality.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Tuberculosis (TB), caused by Mycobacterium tuberculosis com-
plex (MTBC), has been known as part of the human experience for
many thousands of years.1,2 The successful spread of TB worldwide
reﬂects the effective mechanism of immune escape from the host
immune response, favoring natural selection in M. tuberculosis
strains.1,3 Due to the application of effective anti-mycobacterial
drugs, the prevalence of TB appeared to be under control.4,5
Unfortunately, the emergence of drug-resistant TB, especially
multidrug-resistant (MDR)-TB, deﬁned as resistance to at least* Corresponding author. Tel.: +86 10 58900779; fax: +86 10 58900779.
E-mail address: pangyu@chinatb.org (Y. Pang).
1 These authors contributed equally to this study.
http://dx.doi.org/10.1016/j.ijid.2014.05.020
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).isoniazid and rifampin, has had a signiﬁcant negative impact on TB
control.6
The advance in molecular epidemiological tools has provided a
reliable way to investigate molecular evolution over shorter and
longer periods of time.7–10 For M. tuberculosis, the application of
several molecular markers harboring different molecular clocks
has allowed us to access its complicated evolutionary history.10
IS6110-restriction fragment length polymorphism (RFLP) DNA
ﬁngerprinting has been the genotyping technique used most
widely for M. tuberculosis.11 Despite providing high discriminatory
power, this method is limited by its requirement for large
quantities of high-quality DNA and cumbersome procedures.
Recently, several PCR-based genotyping methods have been
developed to compensate for the limitations of RFLP, including
spoligotyping and mycobacterial interspersed repetitive unit–
variable number tandem repeat typing (MIRU-VNTR), which has
been considered as a good alternative method to RFLP.12ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Distribution of spoligotypes shared by Mycobacterium tuberculosis in this study
Family Cladea SITb No. of isolates
New cases Re-treated
cases
Total (%)
Beijing Beijing 1 65 78 143 (69.8)
190 3 0 3 (1.4)
260 0 1 1 (0.5)
269 2 0 2 (1.0)
621 0 7 7 (3.4)
Non-Beijing T1 53 10 3 13 (6.3)
913 0 1 1 (0.5)
522 3 0 3 (1.4)
T2 52 2 0 2 (1.0)
1161 2 0 2 (1.0)
MANU2 54 2 5 7 (3.4)
LAM9 803 1 0 1 (0.5)
H3 50 0 1 1 (0.5)
H3 294 1 0 1 (0.5)
S 1211 1 0 1 (0.5)
Others NAc 13 7 20 (9.6)
Total 105 103 208 (100.0)
a Representing spoligotype families annotated in the SITVITWEB database.
b SIT from SITVITWEB database.
c NA represents the spoligotyping type that is not found in the SITVITWEB
database.
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China and has been classiﬁed as a hotspot for MDR-TB.13 A recent
epidemiological study demonstrated that the rates of primary and
acquired MDR-TB were 3.8% and 26.9%, respectively.13 Neverthe-
less, we still have no knowledge of the potential transmission
proﬁle of MDR-TB in this resource-limited region. In this study, in
order to provide the basis for implementing control strategies for
Chongqing, a total of 208 MDR M. tuberculosis isolates were
genotyped by spoligotyping and MIRU-VNTR. The relationship
between the molecular characteristics and drug susceptibility of
phenotypes was also analyzed.
2. Materials and methods
2.1. Ethics statement
This study was approved by the Ethics Committee of the
Chinese Center for Disease Control and Prevention. Patients were
allowed to enter the study after agreeing to participate and signing
an informed consent form.
2.2. Bacterial strains and culture conditions
From October 2011 to June 2013, a total of 208 MDR
M. tuberculosis isolates, determined by conventional proportional
drug susceptibility test,6 were collected from 1976 smear-positive
TB patients who were registered at local TB dispensaries in
Chongqing. The concentrations of drugs in media were as follows:
isoniazid 0.2 mg/ml, rifampin 40 mg/ml, ethambutol 2 mg/ml,
streptomycin 4 mg/ml, oﬂoxacin 2 mg/ml, and kanamycin 30 mg/
ml. A strain was declared resistant to a drug when the growth rate
was >1% compared with the control. The MDR M. tuberculosis
strains were deﬁned as those resistant to both isoniazid and
rifampin. All the isolates were subcultured on Lowenstein–Jensen
medium.
2.3. Extraction of genomic DNA
Genomic DNA was extracted from freshly cultured bacteria, as
reported previously.12 Following centrifugation at 13 000 rpm for
2 min, the bacterial cells were transferred to a microcentrifuge
tube containing 500 ml Tris–ethylenediaminetetraacetic acid (TE)
buffer. The supernatant was discarded and the pellet was
resuspended in 500 ml TE buffer and heated in a 95 8C water bath
for 1 h. The cellular debris was isolated by centrifugation at
13 000 rpm for 5 min and the DNA in the supernatant was used for
PCR ampliﬁcation reactions.
2.4. Genotyping
Spoligotyping was performed with a commercially available kit,
in accordance with the manufacturer’s instructions and a
published report (Isogen Bioscience BV, Maarssen, Netherlands).14
The original binary data were submitted to the SITVITWEB
database to obtain the spoligotyping pattern.15 Isolates were
assigned shared spoligotype international types (SIT) by the
SITVITWEB database. Beijing genotype strains were deﬁned as
those with the pattern that hybridized to at least three signals from
the last nine spacer oligonucleotides (spacers 35 to 43) and the
absence of hybridization to spacers 1 to 34.16
In addition, the MIRU-VNTR typing method based on a 10-
locus VNTR set with high discriminatory power was carried out
to determine the composition of strains isolated from patients, as
described previously in the literature.13 The composition of
20 ml PCR mixture was as follows: 10 ml 2  PCR Mix, 2 ml of
DNA template containing approximately 2 ng genomic DNA,0.2 mM of each primer set. The PCR was performed under the
following conditions: initial denaturation at 94 8C for 5 min,
and then 35 cycles of 94 8C for 1 min, 60 8C for 1 min, and 72 8C
for 1 min, followed by a ﬁnal extension at 72 8C for 10 min. The
copy number at each locus was calculated according to the repeat
and ﬂank length. The Hunter–Gaston discriminatory index
(HGDI) was used to evaluate the discriminatory power of the
MIRU-VNTR loci, as reported previously.17 The primers used in
the study were all synthesized by Tsingke Company (Beijing,
China).
2.5. Data analysis
BioNumerics software version 5.0 (Applied Maths, Sint-
Martens-Latem, Belgium) was used to cluster the genotyping
patterns, including spoligotyping and MIRU-VNTR. A minimum
spanning tree was constructed by the UPMGA (unweighted pair
group method with arithmetic mean) algorithm. We performed a
Chi-square test to evaluate the associations among multiple
categorical variables, and all calculations were performed using
SPSS 11.5 software (SPSS Inc., Chicago, IL, USA). Differences with a
p-value of 0.05 or less were considered to be statistically
signiﬁcant.
3. Results
3.1. Spoligotyping
Among the 208 MDR M. tuberculosis strains, 156 (75.0%)
belonged to Beijing genotype, while the other 52 (25.0%) were non-
Beijing genotype. Strains classiﬁed into non-Beijing families
included 17 strains from the T1 family (8.2%), four from the T2
family (1.9%), seven from the MANU2 family (3.4%), two from the
H3 family (1.0%), one from the LAM9 family (0.5%), one from the S
family (0.5%), and 20 of undeﬁned genotypes (9.6%). Clustering
analysis revealed that SIT1 was the largest lineage (69.8%, 143),
belonging to the classical Beijing genotype. The second largest
lineage was SIT53, assigned to the ill-deﬁned T1 family, with
13 strains (6.3%) (Table 1).
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In addition, the 208 strains were clustered into 193 genotypes
by the 10-locus VNTR set. Out of 193 genotypes, 181 isolates had a
unique pattern, while the other 27 isolates belonged to 12 clusters
(2–4 isolates per cluster), and the cumulative clustering rate was
12.98% and the HGDI was 0.9991 (Table 2). The cumulative
clustering rates of Beijing genotype and non-Beijing genotype
strains were 14.74% and 7.69%, respectively, while there was no
statistical difference between the Beijing group and non-Beijing
group (p > 0.05).
The allelic diversity of each MIRU-VNTR locus was evaluated
using the HGDI. Overall, the HGDI of six loci (QUB18, Mtub21,
QUB26, QUB11b, QUB11a, and MIRU26) exceeded 0.6, classiﬁed as
highly discriminating loci. The other four loci showed moderate
discrimination (0.3  HGDI  0.6). In addition, we observed that
two highly discriminatory loci (MIRU26 and MIRU10) for non-
Beijing strains showed more allelic diversity than Beijing strains
(Table 3).
A dendrogram was generated based on the genotypes of the
208 isolates using 10 loci (Figure 1). All the isolates were divided
into ﬁve clusters according to phylogenetic clustering and
genotypic characteristics.
3.3. Drug-susceptibility patterns of the MTB isolates and demographic
characteristics
The demographic characteristics and drug susceptibility
proﬁles were analyzed for the Beijing lineage and non-Beijing
lineages. As shown in Table 4, statistical analysis revealed that
there were signiﬁcantly more re-treated patients (odds ratio 2.261,
95% conﬁdence interval 1.178–4.342; p = 0.013) among MDR-TB
patients infected with Beijing genotype strains, while theTable 2
Discriminatory index and clustering rate of the 10-locus set applied to different
Mycobacterium tuberculosis strains
Isolates Total
No. of
isolates
No. of
clustered
isolates
No. of
isolates
in each
cluster
Clustering
rate (%)
HGDI
Beijing genotype 156 23 2–4 14.74% 0.9986
Non-Beijing
genotype
52 4 2 7.69% 0.9985
New cases 105 10 2–4 9.52% 0.9984
Re-treated cases 103 10 2 9.71% 0.9990
Total 208 27 2–4 12.98% 0.9991
HGDI, Hunter–Gaston discriminatory index.
Table 3
Allelic diversity of 10 different MIRU-VNTR loci among Mycobacterium tuberculosis
strains
Locus HGDI
(All)
HGDI
(Beijing
genotype)
HGDI
(Non-Beijing
genotype)
1 QUB18 0.838 0.763 0.753
2 Mtub21 0.814 0.752 0.793
3 QUB26 0.794 0.765 0.848
4 QUB11b 0.779 0.767 0.811
5 QUB11a 0.741 0.755 0.666
6 MIRU26 0.717 0.682 0.800
7 ETRE 0.600 0.588 0.580
8 Mtub04 0.552 0.559 0.534
9 MIRU10 0.539 0.469 0.670
10 ETRF 0.487 0.490 0.483
MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number tandem
repeat; HGDI, Hunter–Gaston discriminatory index.percentages of the drug susceptibility proﬁles, including strepto-
mycin, ethambutol, oﬂoxacin, kanamycin, and extensively drug-
resistant TB (XDR-TB), showed no difference between the Beijing
genotype and non-Beijing genotype. Furthermore, our data
revealed no statistically signiﬁcant difference in several socio-
demographic characteristics, including sex and age (p > 0.05).
4. Discussion
Drug resistance in MDR-TB is a major public health challenge
that is threatening the target for TB elimination of the World
Health Organization (WHO).18 The transmission of M. tuberculosis
is a spontaneous factor that has presumably fueled the worldwide
problem of emerging resistance.19 Thus, an investigation of the
transmission proﬁle of MDR M. tuberculosis isolates in high-burden
MDR-TB regions may have important implications for TB control
programs. In the present study, our data demonstrated that the
Beijing genotype was highly prevalent among MDR M. tuberculosis
isolates circulating in Chongqing, which was higher than the
proportion (66.7%) from all smear-positive patients in this setting.
Beijing genotype is one of the predominant spoligotypes world-
wide, especially in eastern Asia, South Africa, and northern
Eurasia.20–23 As shown in many, albeit not all settings, this well-
known genotype is signiﬁcantly associated with multidrug
resistance and has been responsible for outbreaks of MDR-TB in
several parts of the world.23Figure 1. Dendrogram of 208 MDR Mycobacterium tuberculosis isolates from
Chongqing. The phylogenetic tree was generated from the MIRU-VNTR proﬁle.
Table 4
Differences in characteristics between Beijing and non-Beijing MDR Mycobacterium tuberculosis isolates
Characteristics Total No. of isolates No. (%) of isolates OR 95% CI p-Value
Beijing
(n = 156)
Non-Beijing
(n = 52)
Resistance to
SM 132 98 (62.8%) 34 (65.4%) 0.895 0.464–1.726 0.739
EMB 96 73 (46.8%) 23 (44.2%) 1.109 0.590–2.085 0.748
OFL 51 42 (26.9%) 9 (17.3%) 1.760 0.790–3.921 0.163
KAN 26 17 (10.9%) 9 (17.3%) 0.584 0.243–1.405 0.226
XDR-TBa 6 4 (2.6%) 2 (3.8%) 0.658 0.117–3.701 0.641
Sex
Male 159 121 (77.6%) 38 (73.1%) - - -
Female 49 35 (22.4%) 14 (26.9%) 1.274 0.621–2.614 0.509
Age group, years
<25 8 7 (4.5%) 1 (1.9%) 2.136 0.246–18.532 0.677
25–44 77 59 (37.8%) 18 (34.6%) - - -
45–64 94 72 (46.2%) 22 (42.3%) 0.998 0.490–2.034 0.997
>65 29 18 (11.5%) 11 (21.2%) 0.499 0.200–1.249 0.134
Treatment history
New case 105 71 (45.5%) 34 (65.4%) - - -
Re-treated 103 85 (54.5%) 18 (34.6%) 2.261 1.178–4.342 0.013
MDR, multidrug-resistant; OR, odds ratio; CI, conﬁdence interval; SM, streptomycin; EMB, ethambutol; OFL, oﬂoxacin; KAN, kanamycin; XDR-TB, extensively drug-resistant
tuberculosis.
a XDR is deﬁned as an M. tuberculosis strain resistant to isoniazid, rifampin, OFL, and KAN.
D. Zhang et al. / International Journal of Infectious Diseases 29 (2014) 7–1110Consistent with previous reports, the high proportion of Beijing
genotype in the present study indicates that the Beijing genotype
isolates may be more suited to survival by drug selection pressure,
and are developing into MDR M. tuberculosis isolates. In support of
this hypothesis, we also found that re-treatment cases were more
likely to be associated with the Beijing genotype. A recent study
showed that Beijing genotype strains harbor high rates of mutation
within a wide range of drug concentrations, which may serve as a
possible mechanism for explaining the association of this genotype
with MDR-TB.19 Further studies on the molecular characterization
of MDR M. tuberculosis isolates are needed to verify this hypothesis.
A 10-locus VNTR set has been demonstrated to be a convenient
and effective genotyping method for classifying the lineage of
M. tuberculosis circulating in Chongqing, especially for distinguish-
ing individual Beijing genotype strains.13 Hence, this 10-locus
VNTR method was used to assess the 208 MDR M. tuberculosis
strains in this study. Our MIRU-VNTR data indicated that the
majority of the strains had unique proﬁles, which is suggestive of a
lack of transmission in this region. Chongqing Municipality has a
large ﬂoating population in rural regions, and the frequent
migration of ﬂoating populations may be responsible for the high
discriminatory power in this study. In addition, our data
demonstrated that the 10-locus VNTR set produced a higher HGDI
value (0.9991) and lower clustering rate (12.98%) than in a
previous report (HGDI 0.998, clustering rate 15.8%).13 One possible
explanation for this ﬁnding may be that half of the strains used in
this study were isolated from re-treatment patients, which may be
due mainly to relapse rather than recent transmission.
Yang et al. concluded that Beijing strains of M. tuberculosis were
signiﬁcantly associated with genotypic clustering. Similarly, our
VNTR genotyping data also showed that Beijing genotype strains
were more likely to be clustered, even though the difference was
not statistically signiﬁcant; this can be attributed to the small
sample size. Furthermore, an association was observed between
the re-treatment group and the Beijing lineage. The successful
emergence of this speciﬁc family among re-treated TB patients
indicates that the Beijing lineage may harbor better ﬁtness to
escape from the selection from anti-TB drugs.
Several previous studies have indicated that VNTR loci reveal
different discriminatory power among M. tuberculosis isolates
circulating in geographically diverse areas.24–27 Many previousstudies have demonstrated that Mtub21 serves as a moderately
polymorphic VNTR locus in some regions of China, including
Beijing, Shanghai, and Jiangsu.24,26,27 In contrast, Mtub21 showed
high discriminatory power for the M. tuberculosis strains isolated
from Sichuan and Chongqing, both of which are located in the
southwest of China.13,28 Consistent with the latter ﬁndings, the
HGDI of the Mtub21 locus reached 0.814 for MDR M. tuberculosis
isolates from Chongqing in this study. The variation in the
discriminatory power of Mtub21 among different studies may be
attributed to the diversity of M. tuberculosis strains in the distinct
geographic areas of China. In agreement with a recent report by Lu
et al.,24 we also observed that MIRU26 and MIRU10 have different
powers of discrimination between Beijing genotype and non-
Beijing genotype strains, indicating that MIRU26 and MIRU10 may
be evolutionarily informative VNTR loci to distinguish Beijing
strains from non-Beijing genotype strains.
Strikingly, our observations demonstrated an extremely large
proportion of the isolates to be resistant to streptomycin and
ethambutol. Streptomycin is not used commonly in the regimens
for re-treatment TB cases in China, while ethambutol still plays an
important role in the chemotherapy of drug-resistant TB, including
MDR-TB. The high proportion of ethambutol resistance among
MDR-TB patients challenges the current recommended regimen
containing ethambutol for the treatment of MDR-TB patients in
this region. In addition, our data revealed that about a third of the
MDR M. tuberculosis strains were resistant to either oﬂoxacin or
kanamycin, but not both. On the one hand, the high prevalence of
second-line drug resistance highlights the urgent need to
formulate a control strategy to reduce abuse and overuse of
second-line anti-TB drugs in Chongqing, and on the other, due to
the increasing emergence of second-line drug resistance among
MDR-TB patients, conventional drug sensitivity testing against
second-line anti-TB is essential to provide an effective regimen for
MDR-TB patients.
In conclusion, this report is the ﬁrst to investigate the genetic
diversity and clinical characteristics of MDR-TB in a resource-
limited region of China. Based on our ﬁndings, Beijing genotype
was the predominant genotype among the isolates of MDR-TB
cases in Chongqing, and the proportion of Beijing genotype in the
re-treated patient group was signiﬁcantly higher than that in the
new patient group. The 10-locus VNTR system demonstrated a
D. Zhang et al. / International Journal of Infectious Diseases 29 (2014) 7–11 11good discriminatory power for genotyping MDR M. tuberculosis
isolates circulating in Chongqing Municipality.
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